Inventor · Stoneham, MA, US

Rita Steeves

14Patents
7h-index
17Co-inventors
59Inventor score

Filing activity: Oct 8, 2004 → Apr 17, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8088387B2 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates Emerging Cross-Sectional Technologies 122 Active
US8198417B2 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Emerging Cross-Sectional Technologies 52 Active
US8163888B2 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Emerging Cross-Sectional Technologies 44 Active
US7989598B2 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Emerging Cross-Sectional Technologies 33 Active
US9809637B2 Transforming growth factor beta receptor II fusion polypeptides Chemistry; Metallurgy 18 Active
US8137669B2 Elimination of heterogeneous or mixed cell population in tumors Chemistry; Metallurgy 7 Active
US8388960B2 Elimination of heterogeneous or mixed cell population in tumors Chemistry; Metallurgy 7 Active
US8603483B2 Anti-integrin immunoconjugates, methods and uses Chemistry; Metallurgy 4 Expired
US10316076B2 Transforming growth factor-beta receptor type II fusion polypeptides Chemistry; Metallurgy 2 Active
US10682392B2 Methods for treating pulmonary hypertension with a TGF-beta type II receptor-FC fusion protein Chemistry; Metallurgy 1 Active
US10745462B2 Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide General 0 Revoked
US10981973B2 Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide Chemistry; Metallurgy 0 Active
US11008377B2 Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides Chemistry; Metallurgy 0 Active
US11951156B2 Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.